PTGDR2 and allergic disease: Nevertheless, our unbiased identification of CRTH2– ILC2 challenges our understanding of human ILC2 biology, and has consequences for the identification of activated human ILC2 and strategies to target these cells in type 2 inflammation in e.g., allergy and asthma.